Cleanslate Medical Group of Texas PLLC

Cleanslate Medical Group of Texas PLLC was paid $160K by Medicaid between Oct 2020 and Mar 2023, across 9 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 49% of everything it billed.

33Billing provider infoCLEANSLATE MEDICAL GROUP OF TEXAS PLLC
ARLINGTON, TX 76010

33aNPI1487192522assigned 02/09/2017

33bProvider typeAdult Mental Health Clinic/Center

28Total paid$160K

24GClaims4,765

24DCodes billed9

24AFirst – last monthOct 2020 – Mar 2023

Compared with peers

Next to other Adult Mental Health Clinic/Center providers in Texas

Rank by total paid#14 of 24

Median peer was paid$360K

This provider vs. median0.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	309	$10K
2021	2,008	$62K
2022	2,011	$69K
2023	437	$18K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	49%	1,906	1,308	$78K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	25%	1,301	774	$39K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	16%	1,091	825	$26K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	10%	373	246	$16K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	19	19	$337.05
86803		<1%	19	19	$186.34
87340		<1%	19	19	$134.96
80076		<1%	19	17	$83.93
36415	Collection of venous blood by venipuncture	0%	18	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAMICK, JESSICA (DIRECTOR)